A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes

NCT02806960 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Drug delivery was below target dose due to partial obstruction by aggregated particles.

Conditions

Interventions

Sponsor

Eli Lilly and Company

Collaborators